Nova Mentis Launches Autism Clinical Study

VANCOUVER, BC, May 6, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…

Nova Mentis Organizes Autism Data Bank in North America

VANCOUVER, BC, April 20, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…

Nova Mentis Establishes Serotonin Research Centre

New Partnership with FourthWall Testing VANCOUVER, BC, March 31, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA)…

Nova Mentis Announces Promising Research Results

Psilocybin formulation Modulates Anxiety-Like Behaviour in Rat Autism Model VANCOUVER, BC, March 29, 2021 /CNW/ – Nova Mentis Life…

Nova Mentis Launches Autism Microbiome Study in the United States

VANCOUVER, BC, March 3, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…

Nova Mentis Autism Clinical Study Approved by Institutional Review Board

VANCOUVER, BC, Feb. 25, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”),…

Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug

VANCOUVER, BC, Feb. 18, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…

Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board

VANCOUVER, BC, Feb. 11, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the…

Nova Mentis Psilocybin Approved for Shipment to Italy

VANCOUVER, BC, Feb. 9, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the…

Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study

VANCOUVER, BC, Jan. 26, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the…

Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board

VANCOUVER, BC, Jan. 13, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the…

Nova Mentis Appoints Dr. Kyle Ambert to Scientific Advisory Board

VANCOUVER, BC, Jan. 4, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the…